Redx Pharma Plc (LON:REDX)

Redx Pharma Plc (LON:REDX)


Share Price
10.00 p
Change
1.5 (17.65 %)
Market Cap
£12.65 m
Proactive Investors - Run By Investors For Investors

Redx Pharma Plc

www.redxpharma.com

Overview

Figures in £(m) unless stated
Sales 0.129
EBITDA -9.981
Operating Profit -9.199
Pre-tax Profit -10.146
Net Profit -8.845
Capex -0.132
Operating Cash Flow -17.177
Net Working Capital 5.755
Key Ratios
EBITDA Margin -7737.209
Operating Profit Margin -71.310 -%
Net Profit Margin -68.566 -%
Capex/Sales (%) 1.023
NWC/Sales (%) -6856.5891472868
Asset Turnover 0.007
Days Inventory 0.000  days
Days Receivable 0.000  days
Days Payable 0.000  days
Performance (Last 3 Years)
Sales CAGR 0.000
EBITDA CAGR n/a
Operating Profit CAGR -
Profit CAGR -
Return on Equity(%) -88.049
Return on Assets(%) -46.543
Return on Invested Capital (ROIC)(%) -88.249
ROIC - WACC n/a
Valuation
Market Cap -
Price to Earnings 0.000
Price to Book Value 3.140
Price to Tangible Book -
Equity to FCF Yield -43.36
Enterprise Value -
EV to Sales -
EV to EBITDA -
EV to Operating Profit -
EV to Invested Capital -
EV to FCF Yield -
Dividend Yield -
Payout Ratio 0
Per Share Data (in GBp unless stated)
Earnings per share -0.070000
Operating Cashflow per share -0.13584249400904
Free Cashflow per share -0.062500
Dividend per share -
NAV per share -
Cash per share -0.062000
Solvency
Intangibles Incl. Excl.
Net debt to Equity % -112.26578764747 -121.15708668789
Cash to Equity % 112.26578764747 -42299887.734212
Gross debt to Equity % 0 0
Gross Debt < 1 Year to Equity - -
Net debt to Assets % 0 0
Net Debt/EBITDA 64.833183047791 -0
Net Interest Cover -10145.000000 n/a
Op Cashflow Interest Cover -17177 n/a
Current Ratio 2.456962 n/a
Quick Ratio 1.845316 n/a
Cash Ratio - n/a (Intangibles collected as non-current)
Dividend Cover - n/a
Key Dates
Latest Dividend Pay date n/a
Latest Ex-Dividend date n/a
Last Annual Results 2018-12-28
Last Interim Results 2018-12-28

Profit/Loss

Figures in £(m) unless stated30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
Sales 0.12930.474-----
Cost of Goods Sold -------
Gross Profit -------
Operating Expenses 9.32817.09114.3929.4314.0143.3282.312
EBITDA -9.9812.341-14.799-8.341-3.771-3.102-2.308
Depreciation & Amortisation -------
EBIT (Operating Profit) -9.19913.383-14.392-9.431-4.014-3.328-2.312
Interest Expense/Income -0.0230.3300.2790.286---
Profit Before Tax -10.1461.646-15.407-8.825-4.263-3.581-2.426
Taxes on Income -1.3010.1180.114-0.650-0.910-0.389-0.323
Net Profit -8.8451.528-15.521-8.175-3.353-3.192-2.103
Net Margin -68.5660.050-----
Net profit/loss per share
Basic EPS -0.0700.014-0.198-0.141-0.052-0.049-0.032
Diluted EPS -0.0700.014-0.198-0.141-0.052-0.049-0.032

Balance sheet

 
Figures in £(m) unless stated 30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
ASSETS        
Tangible Assets -------
Intangible Assets 0.4230.4300.3090.3090.3090.3090.309
Investments -------
Total Fixed Assets 0.6140.6521.4471.4120.6220.6370.605
Stocks -------
Debtors ---0.0211.8580.0050.014
Cash & Equivalents -------
Total Current Assets 9.70527.0377.94812.3446.4374.9991.254
Other Assets n/a        
Total Assets 10.31927.6899.39513.7567.0595.6361.859
LIABILITIES        
Interest bearing debt < 1 year 0.0002.0000.0002.0002.0000.000
Other Trade Creditors < 1 year -------
Total Creditors within 1 year 3.95013.3627.6754.0565.0774.8601.222
Interest bearing debt > 1 year --0.0002.0000.0000.0001.700
Other Trade Creditors > 1 year -------
Total Creditors > 1 year 0.0000.0000.0000.0000.0000.0000.000
Other Liabilities  n/a        
Total Liabilities 4.55513.3627.6756.0565.2394.8602.922
Net Assets(NET Tangible Assets exist) 5.34113.8971.4117.3911.5110.467-1.372
EQUITY        
Called up share capital 1.2651.2650.9360.6500.0070.0060.004
Share Premium 33.26433.26422.52713.51712.3137.9313.040
Profit / loss -29.927-21.082-22.610-7.089-10.652-7.299-4.107
Other Equity 1.1620.8800.8670.6220.1520.1380.000
Shareholders Funds 5.76414.3271.7207.7001.8200.776-1.063
Preference Stock -------
Total Capital Employed 5.76414.3271.7207.7001.8200.776-1.063

Cash flow

Figures in £(m) unless stated 30/09/1830/09/1730/09/1630/09/1530/09/1430/09/1330/09/12
EBITDA -8.8451.528-15.521-8.175-4.263-3.581-2.426
Change in Working Capital -8.3917.6861.1482.0301.181-0.937-0.677
Cash Taxes Paid -------
Cash Interest Paid/Received -------
Other (incl. non-cash items) 0.0230.0020.0360.019---
Net Cash from Operating Activities -17.17714.098-12.507-6.538-2.465-3.947-2.910
Capital Expenditure -0.132-0.154-0.444-0.362-0.054-0.277-0.309
Acquisitions/Disposals -------
Other Investing Activities -------
Net Cashflow from Investing Activities -0.109-0.030-0.442-0.362-0.054-0.277-0.309
Dividends -------
Increase/Decrease in Debt 0.000-1.975-0.025-0.0000.3001.700
Increase/Decrease in Equity 0.00012.36410.00013.4474.3834.8931.062
Other Financing Activities -0.049-6.409-0.704-0.0000.0000.000
Cash from Financing -0.0493.9809.27113.4444.3835.1932.762
Net increase in cash -17.33518.048-3.6786.5441.8640.969-0.457

Directors dealings

Date Director Trans Amount Type Price(p) Value (£) Holding %
- Dr. James Robert Mead - - Incentives - - 1200000.00
- Dominic Nicholas Jackson - - Incentives - - 500000.00
- Mr. Iain Gladstone Ross - - Ords 1.00p - - 600000.00 0.4743911
- Peter Eric Presland LLB,ACA,FInstD - - Ords 1.00p - - 120000.00 0.0948782
- Dr. Bernhard Jurgen Kirschbaum - - Ords 1.00p - - 50000.00 0.0395326
- Mr. Iain Gladstone Ross - - Incentives - - 3600000.00
- Ms. Lisa Mary Whewell Anson - - Incentives - - 3600000.00
2018-04-25 Mr. Iain Gladstone Ross P 150000.00 ORD 1P 11 16500 600000.00 0.4743911
- Mr. Norman Molyneux - - Incentives - - 250425.00
- Dr. Neil David Murray - - Incentives - - 75000.00
2017-12-22 Mr. Iain Gladstone Ross P 102000.00 ORD 1P 20.75 21165 450000.00 0.3557933
2017-12-22 Peter Eric Presland LLB,ACA,FInstD P 120000.00 ORD 1P 22 26400 120000.00 0.0948782
2017-12-22 Mr. Peter McPartland P 120000.00 ORD 1P 22 26400 200782.00 0.1587487
2017-12-27 Dr. Bernhard Jurgen Kirschbaum P 50000.00 ORD 1P 21 10500 50000.00 0.0395326
- Dominic Nicholas Jackson - - Incentives - - 500000.00
2017-11-14 Mr. Iain Gladstone Ross P 348000.00 ORD 1P 18.036 62765 348000.00 0.2751469
- Mr. Norman Molyneux - - ORD 1P - - 283436.00 0.2240992
- Dr. Neil David Murray - - ORD 1P - - 1293671.00 1.0228434
- Dr. Frank Murdoch Armstrong - - ORD 1P - - 46586.00 0.0368333
- Mr. Peter McPartland - - ORD 1P - - 80782.00 0.0638704
- Dr. Frank Murdoch Armstrong - - ORD 1P - - 46586.00 0.0368333
- Mr. Norman Molyneux - - ORD 1P - - 283436.00 0.2240992
- Dr. Neil David Murray - - ORD 1P - - 1293671.00 1.0228434
- Dr. Peter Jackson - - ORD 1P - - 3345428.00 2.6450689
- Dr. Peter Jackson - - ORD 1P - - 3345428.00 2.6450689
- Mr. Peter McPartland - - ORD 1P - - 80782.00 0.0638704
- Dr. Frank Murdoch Armstrong - - Incentives - - 473250.00
- Mr. Norman Molyneux - - Incentives - - 250425.00
- Dr. Neil David Murray - - Incentives - - 75000.00
- Dr. Peter Jackson - - Incentives - - 601275.00
- Mr. Philip John Tottey - - ORD 1P - - 35294.00 0.0279053
- Dr. Derek Lindsay - - ORD 1P - - 2002425.00 1.5832211
2016-04-04 Mr. Philip John Tottey E 35294.00 ORD 1P 42.5 15000 35294.00 0.0377264
- Dr. Neil David Murray - - ORD 1P - - 1265084.00 1.0002410
- Dr. Derek Lindsay - - ORD 1P - - 2002425.00 2.1404260
- Mr. Peter McPartland - - ORD 1P - - 77925.00 0.0616115

Dividends

Temporarily not available. Please try again later.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use